IP Library Granted Patent US 10,806,385
Granted Patent B2
US 10,806,385 · App. 15/545,661 · Granted Oct 20, 2020

Device for measuring concentration of substance in blood, and method for measuring concentration of substance in blood

Inventor: Koichi Yamakawa (Kyoto, JP)
Assignee: National Institutes for Quantum and Radiological Science and Technology
A61B5/1455A61B5/14532A61B5/14546G01N21/55G02F1/3501G02F1/39A61B2090/306A61B2090/3614A61B2562/0233G02F2001/3507H01S3/1603H01S3/1643H01S3/2232
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,806,385
App. No.
15/545,661
Granted
Oct 20, 2020
Kind
B2
Abstract

The concentration of substance in blood is measured non-invasively, with high accuracy and with simple configuration. Laser light generated by a light source is locally irradiated on the body epithelium of a subject, and the resulting diffused reflected light is detected by a light detector. The laser light has a wavelength of 9.26 μm. The laser light is generated by converting and amplifying pulsed excitation light from an excitation light source to a long wavelength. A plate-shaped window that is transparent to mid-infrared light is brought in close contact with the body epithelium. The glucose concentration in interstitial fluid can be calculated using normalized light intensity calculated from a signal ratio of signals from a monitoring light detector and light detector.

Claims (43)

1. A device for measuring a concentration of substance in blood that measures the concentration of the substance that is included in the blood of a body, comprising:

a laser oscillator that oscillates a first laser light having a wavelength that is within the range 2.5 μm to 12 μm, and that is absorbed by the substance;

a light-guiding unit that guides the first laser light to the body, and guides first diffused reflected light that is generated by the first laser light from the body; and

a light-detection unit that detects a light intensity of the first diffused reflected light,

the light-guiding unit comprising: an incident-side optical waveguide that is configured to guide the first laser light to the body; and an exit-side optical waveguide that guides the first diffused reflected light to the light-detection unit,

on a cross section of the light-guiding unit, the incident-side optical waveguide and the exit-side optical waveguide being provided to form a substantially V shape.

2. The device for measuring the concentration of substance in blood according to claim 1 , wherein

the light-guiding unit guides the first laser light to the body at an incident angle of 35° to 85°.

3. The device for measuring the concentration of substance in blood according to claim 1 , wherein

the laser oscillator

is an optical parametric oscillator that uses excitation light having a wavelength that is different than the first laser light and that is emitted from an excitation light source, and that oscillates the first laser light by a first non-linear optical crystal.

4. The device for measuring the concentration of substance in blood according to claim 3 , wherein

the excitation-light source is a passive Q-switched Nd:YAG laser or passive Q-switched Yb:YAG laser.

5. The device for measuring the concentration of substance in blood according to claim 4 , wherein

the excitation-light source oscillates a pulsed excitation light with a repetition frequency of 1 Hz or greater.

6. The device for measuring the concentration of substance in blood according to claim 1 , wherein

the laser oscillator is a carbon dioxide gas laser oscillator.

7. The device for measuring the concentration of substance in blood according to claim 6 , wherein

the laser oscillator oscillates a second laser light having a wavelength within the range 2.5 to 12 μm and that is different than that of the first laser light, and that has a characteristic of being absorbed by the substance less than the first laser light; and

in the light-guiding unit

the incident-side optical waveguide is configured to guide the second laser light to the body, and the exit-side optical waveguide guides second diffused reflected light that is generated by the second laser light to the light-detection unit.

8. The device for measuring the concentration of substance in blood according to claim 7 , wherein

the laser oscillator oscillates the first laser light and the second laser light in a pulsed shape with a repetition frequency of 1 Hz or greater.

9. The device for measuring the concentration of substance in blood according to claim 1 , wherein

the substance is glucose; and

the wavelength of the first laser light is within the range 7.0 μm to 11 μm.

10. A device for measuring a concentration of substance in blood that measures the concentration of the substance that is included in the blood of a body, comprising:

a laser oscillator that oscillates a first laser light having a wavelength that is within the range 2.5 μm to 12 μm, and that is absorbed by the substance;

a light-guiding unit that guides the first laser light to the body, and guides first diffused reflected light that is generated by the first laser light from the body; and

a light-detection unit that detects a light intensity of the first diffused reflected light, wherein

the light-guiding unit comprises:

an incident-side optical waveguide that guides the first laser light to the body; and

an exit-side optical waveguide that guides the first diffused reflected light to the light-detection unit;

the laser oscillator is an optical parametric oscillator that uses excitation light having a wavelength that is different than the first laser light and that is emitted from an excitation light source, and that oscillates the first laser light by a first non-linear optical crystal;

the laser oscillator oscillates a second laser light having a wavelength that is within the range 2.5 to 12 μm and that is different than that of the first laser light, and that has a characteristic of being absorbed by the substance less than the first laser light; and

in the light-guiding unit

the incident-side optical waveguide is configured to guide the second laser light to the body, and the exit-side optical waveguide guides second diffused reflected light that is generated by the second laser light to the light-detection unit.

11. The device for measuring the concentration of substance in blood according to claim 10 , wherein

the optical parametric oscillator comprises a second non-linear optical crystal that generates the second laser light using the excitation light.

12. The device for measuring the concentration of substance in blood according to claim 11 , wherein

in the optical parametric oscillator, the first non-linear optical crystal and the second non-linear optical crystal are arranged in series on an optical path.

13. The device for measuring the concentration of substance in blood according to claim 10 , further comprising

a window that is configured for insertion between the light-guiding unit and the body, and that is made using a material that allows the second laser light to pass through, and has a shape so that when inserted between the light-guiding unit and the body and brought in contact with the body, a space is formed between the window and the body through which the first laser light and the second laser light pass.

Assignments (2)
CHANGE OF NAME Recorded Apr 4, 2022
From: NATIONAL INSTITUTES FOR QUANTUM AND RADIOLOGICAL SCIENCE AND TECHNOLOGY
To: NATIONAL INSTITUTES FOR QUANTUM SCIENCE AND TECHNOLOGY
Reel/Frame 059491/0938 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 2, 2020
From: YAMAKAWA, KOICHI
To: NATIONAL INSTITUTES FOR QUANTUM AND RADIOLOGICAL SCIENCE AND TECHNOLOGY
Reel/Frame 053955/0310 →
Priority Claims (1)
JP 2015-009504 · Jan 21, 2015 · national
Continuity (1)
Related Publication 20180000386A1 · Jan 4, 2018